1,829
Views
45
CrossRef citations to date
0
Altmetric
Original Research

A novel role of breast cancer-derived hyaluronan on inducement of M2-like tumor-associated macrophages formation

, , , , , , & show all
Article: e1172154 | Received 18 Dec 2015, Accepted 24 Mar 2016, Published online: 15 Jun 2016

References

  • Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32:593-604; PMID:20510870; http://dx.doi.org/10.1016/j.immuni.2010.05.007
  • Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002; 23:549-55; PMID:12401408; http://dx.doi.org/10.1016/S1471-4906(02)02302-5
  • Chen J, Yao Y, Gong C, Yu F, Su S, Chen J, Liu B, Deng H, Wang F, Lin L et al. CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3. Cancer Cell 2011; 19:541-55; PMID:21481794; http://dx.doi.org/10.1016/j.ccr.2011.02.006
  • Medrek C, Ponten F, Jirstrom K, Leandersson K. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients. BMC Cancer 2012; 12:306; PMID:22824040; http://dx.doi.org/10.1186/1471-2407-12-306
  • Priceman SJ, Sung JL, Shaposhnik Z, Burton JB, Torres-Collado AX, Moughon DL, Johnson M, Lusis AJ, Cohen DA, Iruela-Arispe ML et al. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy. Blood 2010; 115:1461-71; PMID:20008303; http://dx.doi.org/10.1182/blood-2009-08-237412
  • Goswami S, Sahai E, Wyckoff JB, Cammer N, Cox D, Pixley FJ, Stanley ER, Segall JE, Condeelis JS. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 2005; 65:5278-83; PMID:15958574; http://dx.doi.org/10.1158/0008-5472.CAN-04-1853
  • Herr B, Zhou J, Werno C, Menrad H, Namgaladze D, Weigert A, Dehne N, Brüne B. The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor-1 α in macrophages via sphingosine-1-phosphate and transforming growth factor-β. Blood 2009; 114:2140-8; PMID:19549990; http://dx.doi.org/10.1182/blood-2009-01-201889
  • Weigert A, Schiffmann S, Sekar D, Ley S, Menrad H, Werno C, Grosch S, Geisslinger G, Brüne B. Sphingosine kinase 2 deficient tumor xenografts show impaired growth and fail to polarize macrophages towards an anti-inflammatory phenotype. Int J Cancer 2009; 125:2114-21; PMID:19618460; http://dx.doi.org/10.1002/ijc.24594
  • DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N, Coussens LM. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009; 16:91-102; PMID:19647220; http://dx.doi.org/10.1016/j.ccr.2009.06.018
  • Banerjee S, Lin C-FL, Skinner KA, Schiffhauer LM, Peacock J, Hicks DG, Redmond EM, Morrow D, Huston A, Shayne M et al. Heat shock protein 27 differentiates tolerogenic macrophages that may support human breast cancer progression. Cancer Res 2011; 71:318-27; PMID:21224361; http://dx.doi.org/10.1158/0008-5472.CAN-10-1778
  • Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004; 4:528-39; PMID:15229478; http://dx.doi.org/10.1038/nrc1391
  • Auvinen P, Tammi R, Parkkinen J, Tammi M, Agren U, Johansson R, Hirvikoski P, Eskelinen M, Kosma VM. Hyaluronan in peritumoral stroma and malignant cells associates with breast cancer spreading and predicts survival. Am J Pathol 2000; 156:529-36; PMID:10666382; http://dx.doi.org/10.1016/S0002-9440(10)64757-8
  • Tammi RH, Kultti A, Kosma V-M, Pirinen R, Auvinen P, Tammi MI. Hyaluronan in human tumors: Pathobiological and prognostic messages from cell-associated and stromal hyaluronan. Semin Cancer Biol 2008; 18:288-95; PMID:18468453; http://dx.doi.org/10.1016/j.semcancer.2008.03.005
  • Jiang DH, Liang JR, Fan J, Yu S, Chen SP, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA et al. Regulation of lung injury and repair by toll-like receptors and hyaluronan. Nat Med 2005; 11:1173-9; PMID:16244651; http://dx.doi.org/10.1038/nm1315
  • Duff MD, Mestre J, Maddali S, Yan ZP, Stapleton P, Daly JM. Analysis of gene expression in the tumor-associated macrophage. J Surg Res 2007; 142:119-28; PMID:17597158; http://dx.doi.org/10.1016/j.jss.2006.12.542
  • Mytar B, Woloszyn M, Szatanek R, Baj-Krzyworzeka M, Siedlar M, Ruggiero I, Wieckiewicz J, Zembala M. Tumor cell-induced deactivation of human monocytes. J Leukoc Biol 2003; 74:1094-101; PMID:12960282; http://dx.doi.org/10.1189/jlb.0403140
  • del Fresno C, Otero K, Gomez-Garcia L, Gonzalez-Leon MC, Soler-Ranger L, Fuentes-Prior P, Escoll P, Baos R, Caveda L, García F et al. Tumor cells deactivate human monocytes by up-regulating IL-1 receptor associated kinase-M expression via CD44 and TLR4. J Immunol 2005; 174:3032-40; PMID:15728517; http://dx.doi.org/10.4049/jimmunol.174.5.3032
  • Bourcier S, Sansonetti A, Durand L, Chomienne C, Robert-Lezenes J, Smadja-Joffe F. CD44-ligation induces, through ERK1/2 pathway, synthesis of cytokines TNF-α and IL-6 required for differentiation of THP-1 monoblastic leukemia cells. Leukemia 2010; 24:1372-5; PMID:20508620; http://dx.doi.org/10.1038/leu.2010.100
  • Zhang G, Zhang H, Liu Y, He Y, Wang W, Du Y, Yang C, Gao F. CD44 clustering is involved in monocyte differentiation. Acta Bioch Bioph Sin 2014; 46:540-7; http://dx.doi.org/10.1093/abbs/gmu042
  • Tsuchiya S, Kobayashi Y, Goto Y, Okumura H, Nakae S, Konno T, Tada K. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res 1982; 42:1530-6; PMID:6949641
  • Komohara Y, Ohnishi K, Kuratsu J, Takeya M. Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol 2008; 216:15-24; PMID:18553315; http://dx.doi.org/10.1002/path.2370
  • Larsson K, Kock A, Idborg H, Henriksson MA, Martinsson T, Johnsen JI, Korotkova M, Kogner P, Jakobsson PJ. COX/mPGES-1/PGE(2) pathway depicts an inflammatory-dependent high-risk neuroblastoma subset. Proc Natl Acad Sci USA 2015; 112:8070-5; PMID:26080408; http://dx.doi.org/10.1073/pnas.1424355112
  • Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 2007; 117:1155-66; PMID:17476345; http://dx.doi.org/10.1172/JCI31422
  • Kuang D-M, Wu Y, Chen N, Cheng J, Zhuang S-M, Zheng L. Tumor-derived hyaluronan induces formation of immunosuppressive macrophages through transient early activation of monocytes. Blood 2007; 110:587-95; PMID:17395778; http://dx.doi.org/10.1182/blood-2007-01-068031
  • Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev 2008; 226:205-18; PMID:19161426; http://dx.doi.org/10.1111/j.1600-065X.2008.00706.x
  • Bierie B, Moses HL. Transforming growth factor β (TGF-β) and inflammation in cancer. Cytokine Growth Factor Rev 2010; 21:49-59; PMID:20018551; http://dx.doi.org/10.1016/j.cytogfr.2009.11.008
  • Kim HR, Wheeler MA, Wilson CM, Iida J, Eng D, Simpson MA, McCarthy JB, Bullard KM. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44. Cancer Res 2004; 64:4569-76; PMID:15231668; http://dx.doi.org/10.1158/0008-5472.CAN-04-0202
  • Bourguignon LYW, Gilad E, Rothman K, Peyrollier K. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression. J Biol Chem 2005; 280:11961-72; PMID:15655247; http://dx.doi.org/10.1074/jbc.M411985200
  • Yang C, Cao M, Liu H, He Y, Xu J, Du Y, Liu Y, Wang W, Cui L, Hu J et al. The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. J Biol Chem 2012; 287:43094-107; PMID:23118219; http://dx.doi.org/10.1074/jbc.M112.349209
  • Barbieri I, Pensa S, Pannellini T, Quaglino E, Maritano D, Demaria M, Voster A, Turkson J, Cavallo F, Watson CJ et al. Constitutively active stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of cten. Cancer Res 2010; 70:2558-67; PMID:20215508; http://dx.doi.org/10.1158/0008-5472.CAN-09-2840
  • Siddiquee K, Zhang S, Guida WC, Blaskovich MA, Greedy B, Lawrence HR, Yip ML, Jove R, McLaughlin MM, Lawrence NJ et al. Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity. Proc Natl Acad Sci USA 2007; 104:7391-6; PMID:17463090; http://dx.doi.org/10.1073/pnas.0609757104
  • Iijima J, Konno K, Itano N. Inflammatory alterations of the extracellular matrix in the tumor microenvironment. Cancer 2011; 3:3189-205; PMID:24212952; http://dx.doi.org/10.3390/cancers3033189.
  • Tiainen S, Tumelius R, Rilla K, Hamalainen K, Tammi M, Tammi R, Kosma VM, Oikari S, Auvinen P. High numbers of macrophages, especially M2-like (CD163-positive), correlate with hyaluronan accumulation and poor outcome in breast cancer. Histopathology 2015; 66:873-83; PMID:25387851; http://dx.doi.org/10.1111/his.12607
  • Kobayashi N, Miyoshi S, Mikami T, Koyama H, Kitazawa M, Takeoka M, Sano K, Amano J, Isogai Z, Niida S et al. Hyaluronan deficiency in tumor stroma impairs macrophage trafficking and tumor neovascularization. Cancer Res 2010; 70:7073-83; PMID:20823158; http://dx.doi.org/10.1158/0008-5472.CAN-09-4687
  • Ye XZ, Xu SL, Xin YH, Yu SC, Ping YF, Chen L, Xiao HL, Wang B, Yi L, Wang QL et al. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β 1 signaling pathway. J Immunol 2012; 189:444-53; PMID:22664874; http://dx.doi.org/10.4049/jimmunol.1103248
  • Vigetti D, Rizzi M, Viola M, Karousou E, Genasetti A, Clerici M, Bartolini B, Hascall VC, De Luca G, Passi A. The effects of 4-methylumbelliferone on hyaluronan synthesis, MMP2 activity, proliferation, and motility of human aortic smooth muscle cells. Glycobiology 2009; 19:537-46; PMID:19240269; http://dx.doi.org/10.1093/glycob/cwp022
  • Clarkin CE, Allen S, Wheeler-Jones CP, Bastow ER, Pitsillides AA. Reduced chondrogenic matrix accumulation by 4-methylumbelliferone reveals the potential for selective targeting of UDP-glucose dehydrogenase. Matrix Biol 2011; 30:163-8; PMID:21292001; http://dx.doi.org/10.1016/j.matbio.2011.01.002
  • Funahashi M, Nakamura T, Kakizaki I, Mizunuma H, Endo M. Stimulation of small proteoglycan synthesis by the hyaluronan synthesis inhibitor 4-Methylumbelliferone in human skin fibroblasts. Connect Tissue Res 2009; 50:194-202; PMID:19444760; http://dx.doi.org/10.1080/03008200802684615
  • Okuda H, Kobayashi A, Xia B, Watabe M, Pai SK, Hirota S, Xing F, Liu W, Pandey PR, Fukuda K et al. Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells. Cancer Res 2012; 72:537-47; PMID:22113945; http://dx.doi.org/10.1158/0008-5472.CAN-11-1678
  • Saito T, Dai T, Asano R. The hyaluronan synthesis inhibitor 4-methylumbelliferone exhibits antitumor effects against mesenchymal-like canine mammary tumor cells. Oncol Lett 2013; 5:1068-74; PMID:23426189; http://dx.doi.org/10.3892/ol.2013.1124
  • Lee JH, Lee GT, Woo SH, Ha YS, Kwon SJ, Kim WJ, Kim IY. BMP-6 in renal cell carcinoma promotes tumor proliferation through IL-10-dependent M2 polarization of tumor-associated macrophages. Cancer Res 2013; 73:3604-14; PMID:23633487; http://dx.doi.org/10.1158/0008-5472.CAN-12-4563
  • Jiang D, Liang J, Noble PW. Hyaluronan as an immune regulator in human diseases. Physiol Rev 2011; 91:221-64; PMID:21248167; http://dx.doi.org/10.1152/physrev.00052.2009
  • Hefetz-Sela S, Stein I, Klieger Y, Porat R, Sade-Feldman M, Zreik F, Nagler A, Pappo O, Quagliata L, Dazert E et al. Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation. Proc Natl Acad Sci USA 2014; 111:17582-7; PMID:25422452; http://dx.doi.org/10.1073/pnas.1409700111
  • Carter AB, Monick MM, Hunninghake GW. Both Erk and p38 kinases are necessary for cytokine gene transcription. Am J Respir Cell Mol Biol 1999; 20:751-8; PMID:10101008; http://dx.doi.org/10.1165/ajrcmb.20.4.3420
  • Miranda MB, Johnson DE. Signal transduction pathways that contribute to myeloid differentiation. Leukemia 2007; 21:1363-77; PMID:17443228; http://dx.doi.org/10.1038/sj.leu.2404690
  • Matsukawa A, Takeda K, Kudo S, Maeda T, Kagayama M, Akira S. Aberrant inflammation and lethality to septic peritonitis in mice lacking STAT3 in macrophages and neutrophils. J Immunol 2003; 171:6198-205; PMID:14634136; http://dx.doi.org/10.4049/jimmunol.171.11.6198
  • Takeda K, Clausen BE, Kaisho T, Tsujimura T, Terada N, Forster I, Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 1999; 10:39-49; PMID:10023769; http://dx.doi.org/10.1016/S1074-7613(00)80005-9
  • Lyu JH, Huang B, Park D-W, Baek S-H. Regulation of PHLDA1 Expression by JAK2-ERK1/2-STAT3 Signaling Pathway. J Cell Biochem 2016; 117:483-90; PMID:26239656; http://dx.doi.org/10.1002/jcb.25296
  • Lin W-F, Chen C-J, Chang Y-J, Chen S-L, Chiu I-M, Chen L. SH2B1 β enhances fibroblast growth factor 1 (FGF1)-induced neurite outgrowth through MEK-ERK1/2-STAT3-Egr1 pathway. Cell Signal 2009; 21:1060-72; PMID:19249349; http://dx.doi.org/10.1016/j.cellsig.2009.02.009
  • Kim J, Villadsen R, Sorlie T, Fogh L, Gronlund SZ, Fridriksdottir AJ, Kuhn I, Rank F, Wielenga VT, Solvang H et al. Tumor initiating but differentiated luminal-like breast cancer cells are highly invasive in the absence of basal-like activity. Proc Natl Acad Sci USA 2012; 109:6124-9; PMID:22454501; http://dx.doi.org/10.1073/pnas.1203203109

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.